RANK/RANKL/OPG Signaling in the Brain: A Systematic Review of the Literature
Together with its dominant immunological and bone remodeling involvement, RRO axis, comprising of receptor activator of nuclear factor-κB (RANK), RANK ligand (RANKL), and osteoprotegerin (OPG) signaling, is as well-implicated in CNS functioning and corresponding pathologies. The CNS aspects of RANKL...
Main Authors: | Anton Glasnović, Niall O'Mara, Nataša Kovačić, Danka Grčević, Srećko Gajović |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-11-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fneur.2020.590480/full |
Similar Items
-
The RANK/RANKL/OPG system in tumorigenesis and metastasis of cancer stem cell: potential targets for anticancer therapy
by: Sisay M, et al.
Published: (2017-07-01) -
The participation of RANK, RANKL and OPG in tumor osteolysis
by: Marcin Stanisławowski, et al.
Published: (2009-05-01) -
Baicalin Ameliorates Dexamethasone-Induced Osteoporosis by Regulation of the RANK/RANKL/OPG Signaling Pathway
by: Zhao Y, et al.
Published: (2020-01-01) -
Bone metabolism and RANKL/RANK/OPG trail in periodontal disease
by: Czupkallo Lukasz, et al.
Published: (2016-12-01) -
Targeting the RANKL/RANK/OPG Axis for Cancer Therapy
by: Jie Ming, et al.
Published: (2020-08-01)